Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

被引:17
作者
Bellido, Virginia [1 ]
Aguilera, Eva [2 ]
Cardona-Hernandez, Roque [3 ]
Diaz-Soto, Gonzalo [4 ,5 ]
Perez de Villar, Noemi Gonzalez [6 ]
Picon-Cesar, Maria J. [7 ,8 ,9 ]
Ampudia-Blasco, Francisco Javier [10 ,11 ,12 ,13 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Gest Clin Endocrinol & Nutr, Seville, Spain
[2] Hosp Badalona Germans Trias & Pujol, Endocrinol & Nutr Dept, Hlth Sci Res Inst & Univ, Badalona, Spain
[3] Hosp San Juan Dios, Div Pediat Endocrinol, Barcelona, Spain
[4] Hosp Clin Univ Valladolid, Endocrinol & Nutr Dept, Valladolid, Spain
[5] Univ Valladolid, Valladolid, Spain
[6] Hosp Univ La Paz, Endocrinol & Nutr Dept, Madrid, Spain
[7] Hosp Univ Virgen Victoria, Endocrinol & Nutr Dept, Malaga, Spain
[8] Inst Invest Biomed Malaga, Malaga, Spain
[9] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain
[10] Hosp Clin Univ Valencia, Endocrinol & Nutr Dept, Valencia, Spain
[11] INCLIVA Res Fdn, Valencia, Spain
[12] CIBERDEM, Madrid, Spain
[13] Univ Valencia, Valencia, Spain
来源
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2023年 / 17卷 / 05期
关键词
continuous glucose monitoring; flash glucose monitoring; time in range; hypoglycemia; glycemic variability; ambulatory glucose profile; PREGNANT-WOMEN; INSULIN INFUSION; YOUNG-ADULTS; TYPE-1; HYPOGLYCEMIA; SYSTEM; CARE; MULTICENTER; ADOLESCENTS; INJECTIONS;
D O I
10.1177/19322968221088601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New metrics for assessing glycemic control beyond HbA1c have recently emerged due to the increasing use of continuous glucose monitoring (CGM) in diabetes clinical practice. Among them, time in range (TIR) has appeared as a simple and intuitive metric that correlates inversely with HbA1c and has also been newly linked to the risk of long-term diabetes complications. The International Consensus on Time in Range established a series of target glucose ranges (TIR, time below range and time above range) and recommendations for time spent within these ranges for different diabetes populations. These parameters should be evaluated together with the ambulatory glucose profile (AGP). Using standardized visual reporting may help people with diabetes and healthcare professionals in the evaluation of glucose control in frequent clinical situations. The objective of the present review is to provide practical insights to quick interpretation of patient-centered metrics based on flash glucose monitoring data, as well as showing some visual examples of common clinical situations and giving practical recommendations for their management.
引用
收藏
页码:1326 / 1336
页数:11
相关论文
共 69 条
  • [1] 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S244 - S253
  • [2] 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S83 - S96
  • [3] 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022
    不详
    [J]. DIABETES CARE, 2022, 45 : S97 - S112
  • [4] Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes
    Bahillo-Curieses, Ma Pilar
    Diaz-Soto, Gonzalo
    Vidueira-Martinez, Ana M.
    Torres-Ballester, Irune
    Gomez-Hoyos, Emilia
    de Luis-Roman, Daniel
    [J]. ENDOCRINE, 2021, 73 (01) : 47 - 51
  • [5] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [6] Beck Roy W, 2019, J Diabetes Sci Technol, V13, P614, DOI 10.1177/1932296818822496
  • [7] Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
    Beck, Roy W.
    Bergenstal, Richard M.
    Riddlesworth, Tonya D.
    Kollman, Craig
    Li, Zhaomian
    Brown, Adam S.
    Close, Kelly L.
    [J]. DIABETES CARE, 2019, 42 (03) : 400 - 405
  • [8] Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections A Randomized Trial
    Beck, Roy W.
    Riddlesworth, Tonya D.
    Ruedy, Katrina
    Ahmann, Andrew
    Haller, Stacie
    Kruger, Davida
    McGill, Janet B.
    Polonsky, William
    Price, David
    Aronoff, Stephen
    Aronson, Ronnie
    Toschi, Elena
    Kollman, Craig
    Bergenstal, Richard
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 167 (06) : 365 - +
  • [9] Time-in-range for monitoring glucose control: Is it time for a change?
    Bellido, Virginia
    Pines-Corrales, Pedro Jose
    Villar-Taibo, Rocio
    Ampudia-Blasco, Francisco Javier
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [10] Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes
    Biester, Torben
    Grimsmann, Julia M.
    Heidtmann, Bettina
    Rami-Merhar, Birgit
    Ermer, Uwe
    Wolf, Johannes
    Freff, Markus
    Karges, Beate
    Agena, Dirk
    Bramlage, Peter
    Danne, Thomas
    Holl, Reinhard W.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (03) : 160 - 167